Bad Bugs Need Old Drugs: A Stewardship Program's Evaluation of Minocycline for Multidrug-Resistant Acinetobacter baumannii Infections | Zendy

Debra A. Goff | Zendy; Karri A. Bauer | Zendy; Julie E. Mangino | Zendy

Open Access

Bad Bugs Need Old Drugs: A Stewardship Program's Evaluation of Minocycline for Multidrug-Resistant Acinetobacter baumannii Infections

Author(s) -

Debra A. Goff,

Karri A. Bauer,

Julie E. Mangino

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu593

Subject(s) - medicine , minocycline , acinetobacter baumannii , intensive care unit , mechanical ventilation , antimicrobial stewardship , antibiotics , antimicrobial , prospective cohort study , intensive care medicine , antibiotic resistance , pseudomonas aeruginosa , chemistry , organic chemistry , genetics , bacteria , microbiology and biotechnology , biology

Minocycline is an "old-drug" with Food and Drug Administration approval for the treatment of infection due to Acinetobacter species. The purpose of this study is to describe an Antimicrobial Stewardship Program's evaluation of minocycline for the treatment of patients with multidrug resistant A. baumannii (MDR-AB) infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research